INIS
cancer
100%
humans
100%
growth factors
100%
receptors
100%
metastases
100%
breasts
100%
clinical trials
16%
therapy
16%
molecules
8%
patients
8%
tumors
8%
diseases
8%
reviews
8%
management
8%
quality of life
8%
usa
8%
symptoms
8%
chemotherapy
8%
monoclonal antibodies
8%
Medicine and Dentistry
Metastatic Breast Cancer
100%
Gamma Urogastrone
100%
Epidermal Growth Factor Receptor 2
100%
Trastuzumab
100%
Development
30%
Lapatinib
20%
Therapeutic Procedure
20%
Clinical Trial
20%
Diseases
10%
Adverse Event
10%
Receptor Family
10%
Chemotherapy
10%
Combination Therapy
10%
Epidermal Growth Factor Receptor
10%
Monoclonal Antibody
10%
Cardiotoxicity
10%
Breast Tumor
10%
Symptom
10%
Pertuzumab
10%
Patient
10%
Association
10%
Motivation
10%
Quality of Life
10%
Targeted Therapy
10%
Survival
10%
Pharmacology, Toxicology and Pharmaceutical Science
Metastatic Breast Cancer
100%
Gamma Urogastrone
100%
Epidermal Growth Factor Receptor 2
100%
Trastuzumab
100%
Lapatinib
20%
Diseases
10%
Adverse Event
10%
Combination Therapy
10%
Receptor
10%
Monoclonal Antibody
10%
Epidermal Growth Factor Receptor
10%
Breast Tumor
10%
Cardiotoxicity
10%
Pertuzumab
10%
Survival
10%
Symptom
10%
Neuroscience
Trastuzumab
100%
Epidermal Growth Factor Receptor 2
100%
Lapatinib
20%
Eicosanoid Receptor
10%
Chemotherapy
10%
Monoclonal Antibody
10%
Pertuzumab
10%